Inventor · disambiguated record
Yong Zheng
Also filed as: ZHENG YONG · Zheng yong-tang
12 granted patents·17 pending applications·11 citations·filing 2009–2024
85Inventor score
Files withWUXI BIOLOGICS IRELAND LTD9WUXI BIOLOGICS SHANGHAI CO LTD8SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD4CSTONE PHARMACEUTICALS3CGENETECH SUZHOU CHINA CO LTD1
Top patents by PatentIndex Score
29 records- 0190US11795221B2Monoclonal antibody against human LAG-3, method for preparing the same, and use thereofWUXI BIOLOGICS IRELAND LTD·Filed 2019·Granted Oct 24, 2023·3 cites·19 claims
- 0289US11008391B2Anti-PD-1 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2016·Granted May 18, 2021·4 cites·2 claims
- 0386US11643465B2Anti-PD-1 antibodiesWUXI BIOLOGIES IRELAND LTD·Filed 2021·Granted May 9, 2023·1 cites·9 claims
- 0484US2025313634A1Novel anti-pd-l1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 0582US12371493B2Monoclonal antibody against human LAG-3, method for preparing the same, and use thereofWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2023·Granted Jul 29, 2025·0 cites·18 claims
- 0677US12258419B2Anti-FXI/FXIa antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·1 cites·27 claims
- 0777US10981995B2Anti-PD-L1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2016·Granted Apr 20, 2021·1 cites·17 claims
- 0876US2023348602A1Novel anti-pd-1 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 0973US12180282B2Anti-PD-L1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·18 claims
- 1073US2024101676A1The novel monoclonal antibodies to programmed death 1 (pd-1)CSTONE PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 1172US11414487B2Monoclonal antibodies to programmed death 1 (PD-1)CSTONE PHARMACEUTICALS·Filed 2016·Granted Aug 16, 2022·1 cites·18 claims
- 1267US2023014722A1Novel Monoclonal Antibodies to Programmed DEATH (PD-1)CSTONE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1360US2024285685A1Genetically modified nk cells and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1460US2025161474A1Antibody-drug conjugates targeting egfr/c-met and preparation methods and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1559US2024246927A1Compounds with alk inhibitory activity and preparation method and use thereofCGENETECH SUZHOU CHINA CO LTD·Filed 2023·Application pending·0 cites
- 1657US12054554B2Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereofWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2019·Granted Aug 6, 2024·0 cites·14 claims
- 1757US2025281631A1Antibody-drug conjugates and preparation methods and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1855US12202894B2Anti-TIM-3 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2019·Granted Jan 21, 2025·0 cites·23 claims
- 1954US2025325687A1Conjugate comprising toll-like receptor agonistMABSOFT THERAPEUTICS SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 2053US8790663B2Antigenic determinants of human death receptor DR5LIU YANXIN·Filed 2009·Granted Jul 29, 2014·0 cites·3 claims
- 2153US2024269312A1Antibody drug conjugate, and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2250US2021046154A1Methods of use of soluble cd24 for treating acquired immune deficiency syndrome (hiv/aids)ONCOIMMUNE INC·Filed 2019·Application pending·0 cites
- 2350US2022213192A1Bispecific antibodies against pd-1 and lag-3WUXI BIOLOGICS IRELAND LTD·Filed 2020·Application pending·0 cites
- 2450US2023348609A1Cd40 agonistic antibody and method of useWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2547US10696745B2Anti-PD-L1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2015·Granted Jun 30, 2020·0 cites·11 claims
- 2647US2021115138A1Novel bispecific pd-1/lag-3 antibody moleculesWUXI BIOLOGICS IRELAND LTD·Filed 2019·Application pending·0 cites
- 2747US2021340252A1Anti-tim-3 antibodies and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2019·Application pending·0 cites
- 2846US2022332827A1Humanized antibodies against pd-l1WUXI BIOLOGICS IRELAND LTD·Filed 2020·Application pending·0 cites
- 2941US2021171647A1Fully human antibodies against ox40, method for preparing the same, and use thereofWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yong Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →